410 results on '"Kerridge, Ian H."'
Search Results
2. Perspectives on non-financial conflicts of interest in health-related journals: A scoping review
3. The Outer Limits of Reperfusion Therapy: Finding Benefits on the Fringes
4. Religious Perspectives on Human Suffering: Implications for Medicine and Bioethics
5. Should voluntary assisted dying in Victoria be extended to encompass people with dementia?
6. Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations
7. Secondary Analysis of the MM21 Trial: Response Adaptive Salvage Treatment with Daratumumab-Lenalidomide-Dexamethasone (DRd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
8. Circulating RAS/RAF and DNA-Repair Gene Mutations Associates with High-Risk/Treatment Resistance in Primary Refractory Multiple Myeloma
9. Religious Perspectives on the Use of Psychopharmaceuticals as an Enhancement Technology
10. Religious Perspectives on Abortion and a Secular Response
11. Journal peer review in context: A qualitative study of the social and subjective dimensions of manuscript review in biomedical publishing
12. Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer
13. Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy - Final Analysis from the Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial
14. Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
15. Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index
16. The Effect of Daratumumab, Lenalidomide, Dexamethasone (DRd) on Peripheral Blood Stem Cell Mobilisation (PBSC)
17. A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16)
18. Preliminary Analysis of the MM21 Trial: Response Adaptive Salvage Treatment with Daratumumab-Lenalidomide-Dexamethasone (DRd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
19. 489 - Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study
20. Knowledge, Beliefs, and Decisions of Pregnant Australian Women Concerning Donation and Storage of Umbilical Cord Blood: A Population-Based Survey
21. Formulating an Ethics Agenda for Drug Development, Regulation, and Utilization
22. Regulating complementary, unconventional and emerging treatments in Australia: a missed opportunity
23. “Good Mothering” or “Good Citizenship”?: Conflicting Values in Choosing Whether to Donate or Store Umbilical Cord Blood
24. Should Biomedical Publishing Be “Opened Up”? Toward a Values-Based Peer-Review Process
25. The Legislation of Active Voluntary Euthanasia in Australia: Will the Slippery Slope Prove Fatal?
26. Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study
27. Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study
28. Equity, Utility, and the Marketplace: Emerging Ethical Issues of Umbilical Cord Blood Banking in Australia
29. A narrative account of the impact of positive thinking on discussions about death and dying
30. Gifts, Drug Samples, and other Items Given to Medical Specialists by Pharmaceutical Companies
31. Socioeconomic, demographic and policy comparisons of living and deceased kidney transplantation rates across 53 countries
32. UNCERTAIN TRANSLATION, UNCERTAIN BENEFIT AND UNCERTAIN RISK: ETHICAL CHALLENGES FACING FIRST-IN-HUMAN TRIALS OF INDUCED PLURIPOTENT STEM (IPS) CELLS
33. NARRATIVES OF ‘TERMINAL SEDATION’, AND THE IMPORTANCE OF THE INTENTION-FORESIGHT DISTINCTION IN PALLIATIVE CARE PRACTICE
34. Understanding and Managing Changes in Survivor Identity and Relationships
35. The perils of a vanishing cohort: a study of social comparisons by women with advanced ovarian cancer
36. Ethical issues in bone marrow transplantation in children
37. Evidence, Ethics, and Values: A Framework for Health Promotion
38. Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study
39. A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16)
40. Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study
41. A question of competence
42. An empirical study of tissue banking in Australia: navigating regulatory and ethical challenges.
43. Increasing diversity at the cost of decreasing equity? Issues raised by the establishment of Australia's first religiously affiliated medical school
44. Privacy in the Context of “Re-Emergent” Infectious Diseases
45. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry
46. The intention to hasten death: a survey of attitudes and practices of surgeons in Australia
47. An ethics core curriculum for Australasian medical schools
48. A Longitudinal Evaluation of Euroflow and Combined Quantitative Immunoprecipitation (QIP) and Free Light Chain (FLC) Mass Spectometry (MS) in Functional High Risk Multiple Myeloma
49. Impact of written information on knowledge and preferences for cardiopulmonary resuscitation
50. 'These sorts of people don't do very well': race and allocation of health care resources
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.